• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用记录链接和人工随访评估维多利亚州唐氏综合征、18三体综合征和神经管缺陷的孕产妇血清四联筛查试验。

Using record linkage and manual follow-up to evaluate the Victorian maternal serum screening quadruple test for Down's syndrome, trisomy 18 and neural tube defects.

作者信息

Jaques Alice M, Collins Veronica R, Haynes Kerry, Sheffield Leslie J, Francis Ivan, Forbes Robin, Halliday Jane L

机构信息

Public Health Genetics, Murdoch Childrens Research Institute, Royal Children's Hospital, Australia.

出版信息

J Med Screen. 2006;13(1):8-13. doi: 10.1258/096914106776179782.

DOI:10.1258/096914106776179782
PMID:16569299
Abstract

OBJECTIVES

The Genetic Health Services Victoria maternal serum screening (MSS) quadruple test has been available to pregnant women in Victoria since 1996. The objectives of this study were to follow up the pregnancies screened by MSS between July 1998 and June 2000 and to determine the performance characteristics of the test for Down's syndrome, trisomy 18 and neural tube defects (NTDs).

METHODS

MSS results were matched to pregnancy outcome information from the Perinatal Data Collection Unit and Birth Defects Register, using automated probabilistic record linkage. For unmatched pregnancies, manual follow-up was carried out by contacting referring doctors and hospitals, resulting in a very high follow-up rate of 99.2% (18,989/19,143).

RESULTS

The sensitivity of MSS for Down's syndrome was 85% (23/27-95%CI 72-99%) with a falsepositive rate (FPR) of 6.8% (risk threshold >or= 1 in 250). While using a fixed 5% FPR, the sensitivity for Down's syndrome was slightly lower (78%). The sensitivity for trisomy 18 was 44% (4/9 - 95% CI 12-77%) with a FPR of 0.5% (risk threshold of >or= 1 in 200). 11 of the 15 (73 - 95%CI 51-97%) cases of open NTDs were detected from screening, with a 1% FPR (risk threshold alpha-fetoprotein [AFP] >or=2.5 MoM). All cases of anencephaly had increased AFP levels.

CONCLUSION

Probabilistic record linkage and manual follow-up is an efficient method for ascertainment of pregnancy outcomes, with a higher follow-up rate than that reported in similar studies. MSS should remain an available option for all pregnant women in Victoria, with test characteristics comparable with other recent reports of the quadruple test.

摘要

目的

自1996年起,维多利亚州遗传健康服务机构的孕妇血清筛查(MSS)四联检测就已提供给该州的孕妇。本研究的目的是对1998年7月至2000年6月期间接受MSS筛查的妊娠情况进行随访,并确定该检测对唐氏综合征、18三体综合征和神经管缺陷(NTDs)的性能特征。

方法

利用自动化概率记录链接,将MSS结果与围产期数据收集单位和出生缺陷登记处的妊娠结局信息进行匹配。对于不匹配的妊娠,通过联系转诊医生和医院进行人工随访,随访率高达99.2%(18989/19143)。

结果

MSS对唐氏综合征的敏感性为85%(23/27 - 95%CI 72 - 99%),假阳性率(FPR)为6.8%(风险阈值≥1/250)。在使用固定的5%FPR时,对唐氏综合征的敏感性略低(78%)。对18三体综合征的敏感性为44%(4/9 - 95%CI 12 - 77%),FPR为0.5%(风险阈值≥1/200)。15例开放性NTDs病例中有11例(73 - 95%CI 51 - 97%)通过筛查检测到,FPR为1%(风险阈值甲胎蛋白[AFP]≥2.5倍中位数)。所有无脑儿病例的AFP水平均升高。

结论

概率记录链接和人工随访是确定妊娠结局的有效方法,随访率高于类似研究报告。MSS应继续作为维多利亚州所有孕妇的可用选择之一,其检测特征与其他近期四联检测报告相当。

相似文献

1
Using record linkage and manual follow-up to evaluate the Victorian maternal serum screening quadruple test for Down's syndrome, trisomy 18 and neural tube defects.利用记录链接和人工随访评估维多利亚州唐氏综合征、18三体综合征和神经管缺陷的孕产妇血清四联筛查试验。
J Med Screen. 2006;13(1):8-13. doi: 10.1258/096914106776179782.
2
Follow up and evaluation of the Victorian first-trimester combined screening programme for Down syndrome and trisomy 18.维多利亚州孕早期唐氏综合征和18三体综合征联合筛查项目的随访与评估
BJOG. 2007 Jul;114(7):812-8. doi: 10.1111/j.1471-0528.2007.01349.x. Epub 2007 May 15.
3
Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.使用母体血清甲胎蛋白、人绒毛膜促性腺激素和未结合雌三醇进行产前筛查:在一家健康维护组织中的两年经验。
J Matern Fetal Med. 1996 Mar-Apr;5(2):70-3. doi: 10.1002/(SICI)1520-6661(199603/04)5:2<70::AID-MFM4>3.0.CO;2-N.
4
Maternal serum screening in Ontario using the triple marker test.安大略省使用三联筛查试验进行孕妇血清筛查。
J Med Screen. 2003;10(3):107-11. doi: 10.1177/096914130301000302.
5
Triploidy identified through second-trimester serum screening.通过孕中期血清筛查发现的三倍体。
Prenat Diagn. 2005 Mar;25(3):229-33. doi: 10.1002/pd.1115.
6
[Prenatal serum screening of aneuploidy and of neural tube defects in the second trimester of pregnancy among the population of Luxembourg. Evaluation of risk by the triple test (AFP+THCG+UE3)].[卢森堡人群妊娠中期非整倍体及神经管缺陷的产前血清筛查。三联试验(甲胎蛋白+人绒毛膜促性腺激素+游离雌三醇)风险评估]
Bull Soc Sci Med Grand Duche Luxemb. 1997;134(1):25-9.
7
[Noninvasive serum test for prenatal detection of Down syndrome, other chromosome abnormalities and open neural tube defects--a prospective study].[用于产前检测唐氏综合征、其他染色体异常及开放性神经管缺陷的非侵入性血清检测——一项前瞻性研究]
Geburtshilfe Frauenheilkd. 1994 Jun;54(6):355-61. doi: 10.1055/s-2007-1022854.
8
[Study on key techniques and intervention in reducing birth defects].[降低出生缺陷的关键技术与干预措施研究]
Zhonghua Fu Chan Ke Za Zhi. 2011 Sep;46(9):658-63.
9
Prenatal biochemical screening for Down's syndrome and neural tube defects.唐氏综合征和神经管缺陷的产前生化筛查。
Curr Opin Obstet Gynecol. 1992 Apr;4(2):302-7.
10
Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital.合艾地区医院对唐氏综合征胎儿进行三联标志物血清筛查的经验。
J Med Assoc Thai. 2007 Oct;90(10):1970-6.

引用本文的文献

1
Beyond Trisomy 21: Additional Chromosomal Anomalies Detected through Routine Aneuploidy Screening.超越21三体综合征:通过常规非整倍体筛查检测到的其他染色体异常。
J Clin Med. 2014 Apr 8;3(2):388-415. doi: 10.3390/jcm3020388.